TDAC
Translational Development Acquisition Corp. Ordinary Shares
NASDAQ: TDAC · FINANCIAL SERVICES · SHELL COMPANIES
$10.64
+0.09% today
Updated 2026-05-01
Market cap
$233.31M
P/E ratio
36.72
P/S ratio
—
EPS (TTM)
$0.29
Dividend yield
—
52W range
$10 – $11
Volume
0.0M
Translational Development Acquisition Corp. Ordinary Shares (TDAC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — |
| Cost of revenue | — | — | $320.87M | — |
| Gross profit | — | — | $744.92M | — |
| Gross margin | — | — | — | — |
| R&D | — | — | — | — |
| SG&A | $70662.00 | $485550.00 | $9.13B | $944538.00 |
| Operating income | $-70662.00 | $-485550.00 | $-196358.00 | $-944538.00 |
| Operating margin | — | — | — | — |
| EBITDA | — | $-485550.00 | $-71008.00 | $-944538.00 |
| EBITDA margin | — | — | — | — |
| EBIT | $-70662.00 | $-485550.00 | — | — |
| Interest expense | — | — | $508.56M | — |
| Income tax | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-70662.00 | $-485550.00 | $-71012.00 | $6.36M |
| Net income growth (YoY) | — | -587.1% | +85.4% | +9059.7% |
| Profit margin | — | — | — | — |